Afternoon Updates & Watchlist

Axxess Pharma, Inc. AXXE

After appearing in this morning’s alert, AXXE traded as high as .459 before dipping back to .30, and has come back to .393 as of the time of this publication. From that bottom, it represents an opportunity for an intraday 31%. When added to the many swings that we’ve observed from this bouncy stock since we began following it, the cumulative gains add up to nearly 100%  Volatile stocks like these can be good for rapid gains if properly timed, and we’ve seen evidence of that in AXXE.

Today’s PR:


FreeSeas, Inc. FREE

We’d also like to include an update on FREE, which we recently began tracking on September 10th, when we stated that we were on the lookout for the “next areas of resistance to come at .33 and .38,”.

This afternoon we’re happy to report that yesterday’s trading broke the low barrier at .33. and today the stock punched through the .38-mark to hit a high of .50.

From the low following 09/10 (.2213), today’s high equates to a 126% increase in just over a week.


Extended Watchlist:
EXMT, RAD, DRYS, ZNGA, GOGO FB

AXXE | Axxess Pharma, Inc. & Extended Watchlist

Axxess Pharma, Inc. AXXE
We’re touching base with AXXE again this morning, as the company has made some exciting announcements over the past couple of days including the acquisition of assets previously belonging to Revive Bioscience Inc., a Canadian OTC healthcare company, a move that widens AXXE’s catalog of pharma products significantly. Even more exciting is the fact that Revive held the rights to several branded OTC products endorsed by professional athletes in many major American sports including the NFL, NHL, and more.

Additionally, in a PR from yesterday we learned that AXXE has also made an addition to an already strong management team, with the appointment of Robert Tallack, who will serve as VP of Sales and Marketing. You can read more in depth about both developments by clicking through the press links below, but first, we’re going to take a look at how the AXXE chart is faring via the following video:

Be sure to check out the Exclusive Interview our sister site, Stock Traders Talk, conducted with AXXE President Dr. Daniel Bagi last week:
AXXE Interview

You can also take a look at our initial report on the company:
AXXE Report



Extended Watchlist:
FREE, DRYS, GOGO, RAD